Impel Pharmaceuticals Net Tangible Assets

Impel Pharmaceuticals (IMPL) currently reports a net tangible assets of $-92M as of September 2023. That compares with $-22M in the prior-year period — down 312.3% year over year. Use the charts on this page to explore Impel Pharmaceuticals's net tangible assets history and peer comparisons.

Impel Pharmaceuticals's net tangible assets decreased from $-22M to $-92M — a 312.3% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Impel Pharmaceuticals reported $-92M in net tangible assets as of September 2023. That compares with $-22M in the prior-year period — down 312.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-92M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Impel Pharmaceuticals, and consider following IMPL for alerts when major investors trade the stock.

Impel Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $-92M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMPL with unrelated industries.